JNJ - Johnson & Johnson

NYSE - Nasdaq Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
94,943,000
94,943,000
93,775,000
82,584,000
82,059,000
Cost of revenue
31,089,000
31,089,000
29,855,000
28,427,000
27,556,000
Gross profit
63,854,000
63,854,000
63,920,000
54,157,000
54,503,000
Operating expenses
Research development
15,386,000
15,386,000
14,714,000
12,159,000
11,355,000
Selling general and administrative
24,765,000
24,765,000
24,659,000
22,084,000
22,178,000
Total operating expenses
40,151,000
40,151,000
39,373,000
34,243,000
33,533,000
Operating income or loss
23,703,000
23,703,000
24,547,000
19,914,000
20,970,000
Interest expense
276,000
276,000
183,000
201,000
318,000
Total other income/expenses net
-2,192,000
-2,192,000
-1,641,000
-3,327,000
-3,681,000
Income before tax
21,725,000
21,725,000
22,776,000
16,497,000
17,328,000
Income tax expense
3,784,000
3,784,000
1,898,000
1,783,000
2,209,000
Income from continuing operations
17,941,000
17,941,000
20,878,000
14,714,000
15,119,000
Net income
17,941,000
17,941,000
20,878,000
14,714,000
15,119,000
Net income available to common shareholders
17,941,000
17,941,000
20,878,000
14,714,000
15,119,000
Basic EPS
-
6.86
7.93
5.59
5.74
Diluted EPS
-
6.73
7.81
5.51
5.63
Basic average shares
-
2,613,597
2,632,100
2,632,800
2,632,507
Diluted average shares
-
2,663,900
2,674,000
2,670,700
2,684,300
EBITDA
-
23,703,000
24,547,000
19,914,000
20,970,000